http:
TRANSCRIPT
Marijuana use in adolescence and adulthood Risk factor for schizophrenia Worse outcomes
frequent and longer periods of hospitalization higher relapse rates even in first-episode patients elevated rates of extrapyramidal motor symptoms
(EPS), lower medication compliance higher rates of unemployment, violence, higher rate of criminality increased risk of suicide
Side effects of heavy marijuana use
Barnett et al. 2007Verdoux and Tournier 2004Stefanis et al. 2004
Patients with cannabis abuse/dependence smaller fronto-temporal WM volumes
Significant CNR1 (rs12720071) genotype-by-marijuana-use effects on WM volumes neurocognitive impairment
Side effects of heavy marijuana use
Agarwal et al,2009
CVS ( n=82)
Functional vomiting (n=62)
Odds ratio for CVS( 95% CI)
P value
Age (mean±SD)
30±11 36±13 0.7(0.5-0.9)
0.005
GenderFemale ( n=71)Male (n=73)
33 (40%)49 (60%)
38 (61%)24 (39%)
0.4(.2-0.9) 0.02
Cannabis use
30 (37%) 8 (13%) 2.9(1.2-7.2)
0.02
Retching 55 (67%) 25 (40%) 4.4(2-9.7) 0.0003
Depression 2 (2%) 4 (6%) 0.4(1.2-2.6)
0.35
Anxiety 1 (1%) 2 (3%) 0.3(.03-4.5)
0.41
Other psychiatric disorders
11 (13%) 21 (34%) 0.3(0.1-0.7)
0.006
Marijuana use in CVS
Choung R.S.et al, Neurogastroenterology and Motility, 2012
Retrospective chart reviews Review of 31 published case reports Case series of 98 patients
Association with chronic, daily marijuana use Long duration of use preceding onset of
symptoms (2-10 years) Duration of follow up ( variable)
Cannabinoid hyperemesis syndrome
Wallace E.A. et al, S Med Journal, 2011Simonetto DA et al, Mayo Clinic Proceedings, 2012
Total of 437 patients with CVS Mean age was 34 ± 12 Mostly Caucasian (92%) Eighty-one % of patients reported use of
marijuana to treat their symptoms Marijuana users were more likely to be male
and have associated anxiety
An Internet survey of marijuana use in CVS
Experimental Brain research,2014
Self reported effects of marijuana in patients with CVS
0
10
20
30
40
50
60
70
80
90
100
Overallsymptoms Nausea Vomiting Appetite General
well-beingStress level Vertigo
Perc
enta
ges
Made a lotbetterNo difference
Made a lotworse
Venkatesan et al, International Conference of Nausea & Vomiting,Pittsburgh,2013
Hypothesis
The activity of the endocannabinoid system (ECS) is significantly altered with an associated increase in salivary cortisol and alpha amylase.
CVS patients n=22
Controls n=12
P value
Age 40±11 37±12 NS
GenderFemaleMale
17 (77%)5 (23%)
10 (83%)2 (17%)
NS
BMI 29.7 28.6 NS
Marijuana use 8 (40%) 0 (0%) 0.002 *
Pittsburgh Sleep Quality Index (PSQI) scores
12 ± 1 6 ± 1 0.0008 *
Anxiety 10 ± 1 5 ± 1 0.002 *
Depression 7 ± 0.4 1.6 ± 1 0.002 *
Baseline characteristics
Serum 2-AG and NAE concentrations in CVS patients and controls
Data analyzed using one way ANOVA ,comparisons between groups were carried out using Bonferroni’s t-tests. * p<0.05; **p<0.01.
Venkatesan et al ,DDW2013
Variable Patients – well phase
Patients - sick phase
Controls P value (Sick vs well phase in patients)
Salivary cortisol(s cort)
6.7 (4.0-19.5) 16 (2.6-51.4) 10.5 (3.4-11.3)
0.09
Salivary alpha amylase
214 (13.5-272.2)
285 (11.5-586.0)
138 (44.2-322.0)
NS
Salivary cortisol (nmol/L; median [range]), and salivary alpha amylase (U/ml; median [range]) in
the well phase and during an episode in CVS patients and controls
Venkatesan et al ,DDW2013